Turnstone Biologics Corp.
DelistedCIK 1764974fmd_01B5WFZ3XTMHA96C4JNM6P8A4QManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2022 to Jun 30, 2025, 14 periods
| Line item | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| Total revenues | 73 | 19 | – |
| Research and development | 87 | 60 | 56 |
| Total operating expenses | 105 | 78 | 72 |
| Operating income | (32) | (59) | (72) |
| Other non-operating income (expense) | 1 | 4 | 2 |
| Income before taxes | (31) | (55) | (71) |
| Income tax expense | 0 | (0) | 0 |
| Net income from continuing operations | (31) | (55) | (71) |
| Net income | (31) | (55) | (71) |
| Net income to common shareholders | (31) | (55) | (71) |